Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Chem Commun (Camb) ; 55(60): 8868-8871, 2019 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-31240288

RESUMO

New evidence on the role of H2S as a gasotransmitter suggests that the true signalling effectors are polysulfides. Both oxidized polysulfides and hydropolysulfides were synthesized and their presence in S. cerevisiae was observed for the first time. A single gene-deletant approach allowed observation of the modulation of polysulfide species and levels.


Assuntos
Gasotransmissores/análise , Saccharomyces cerevisiae/química , Sulfetos/análise , Proteínas de Transporte/genética , Cistationina beta-Sintase/genética , Cistationina gama-Liase/genética , Gasotransmissores/síntese química , Gasotransmissores/metabolismo , Deleção de Genes , Metabolômica/métodos , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/metabolismo , Proteínas de Saccharomyces cerevisiae/genética , Sulfetos/síntese química , Sulfetos/metabolismo
2.
Angew Chem Int Ed Engl ; 55(51): 15846-15851, 2016 12 19.
Artigo em Inglês | MEDLINE | ID: mdl-27879021

RESUMO

Prodrug strategies have been proven to be a very effective way of addressing delivery problems. Much of the chemistry in prodrug development relies on the ability to mask an appropriate functional group, which can be removed under appropriate conditions. However, developing organic prodrugs of gasotransmitters represent unique challenges. This is especially true with carbon monoxide, which does not have an easy "handle" for bioreversible derivatization. By taking advantage of an intramolecular Diels-Alder reaction, we have developed a prodrug strategy for preparations of organic CO prodrugs that are stable during synthesis and storage, and yet readily release CO with tunable release rates under near physiological conditions. The effectiveness of the CO prodrug system in delivering a sufficient quantity of CO for possible therapeutic applications has been studied using a cell culture anti-inflammatory assay and a colitis animal model. These studies fully demonstrate the proof of concept, and lay a strong foundation for further medicinal chemistry work in developing organic CO prodrugs.


Assuntos
Anti-Inflamatórios/síntese química , Monóxido de Carbono/síntese química , Reação de Cicloadição/métodos , Gasotransmissores/síntese química , Pró-Fármacos/síntese química , Animais , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Monóxido de Carbono/química , Monóxido de Carbono/farmacologia , Colite/tratamento farmacológico , Gasotransmissores/química , Gasotransmissores/farmacologia , Camundongos , Pró-Fármacos/química , Pró-Fármacos/farmacologia , Células RAW 264.7
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...